Eli Lilly's Obesity Pill: A New Era Begins
Kilder
- Nature: The 1000 Chinese Pangenome empowers medical and population genetics - Nature
- Nature: Gene regulatory landscape dissected by single-cell four-omics sequencing - Nature
- Nature: NADPH-producing enzymes restrict the formation of pancreatic precancerous lesions - Nature
- Statnews: Eli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk - statnews.com
- Biopharmadive: FDA approves Lilly obesity pill, triggering battle with Novo Nordisk - BioPharma Dive
- Biospace: Ambrosia Eyes Next-Generation Small Molecule GLP-1s With $100M Series B - BioSpace
- wikimedia: Photo by Weatherbee, B.A.T., Weberling, A., Gantner, C.W. et al. / Wikimedia Commons / CC BY 4.0
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.